These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22023531)

  • 1. Surface profiles for subclassification of chronic lymphocytic leukemia.
    Huang PY; Best OG; Belov L; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2012 Jun; 53(6):1046-56. PubMed ID: 22023531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
    Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
    J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia.
    Abousamra NK; Salah El-Din M; Hamza Elzahaf E; Esmael ME
    Leuk Lymphoma; 2015 Jan; 56(1):113-9. PubMed ID: 24684231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Mactier S; Armacki N; Giles Best O; Belov L; Kaufman KL; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2016 May; 57(5):1033-43. PubMed ID: 26422656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia.
    Perry C; Hazan-Halevy I; Kay S; Cipok M; Grisaru D; Deutsch V; Polliack A; Naparstek E; Herishanu Y
    Ann Hematol; 2012 Aug; 91(8):1271-9. PubMed ID: 22349724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
    Joshi AD; Hegde GV; Dickinson JD; Mittal AK; Lynch JC; Eudy JD; Armitage JO; Bierman PJ; Bociek RG; Devetten MP; Vose JM; Joshi SS
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5295-304. PubMed ID: 17875758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis.
    Tooze JA; Hamzic E; Willis F; Pettengell R
    Cancer Genet; 2017 Dec; 218-219():20-38. PubMed ID: 29153094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunophenotype of chronic lymphocytic leukemia and prolymphocytic leukemia].
    Maruyama S
    Nihon Rinsho; 1992 Jun; 50(6):1236-40. PubMed ID: 1518139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of gene expression signatures for molecular classification in human leukemia cells.
    Song JH; Kim HJ; Lee CH; Kim SJ; Hwang SY; Kim TS
    Int J Oncol; 2006 Jul; 29(1):57-64. PubMed ID: 16773185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypes.
    Huang PY; Kohnke P; Belov L; Best OG; Mulligan SP; Christopherson RI
    J Pharm Pharm Sci; 2013; 16(2):231-7. PubMed ID: 23958192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing Molecular Signatures for Chronic Lymphocytic Leukemia.
    Cornet E; Debliquis A; Rimelen V; Civic N; Docquier M; Troussard X; Drénou B; Matthes T
    PLoS One; 2015; 10(6):e0128990. PubMed ID: 26046539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.
    Marina O; Hainz U; Biernacki MA; Zhang W; Cai A; Duke-Cohan JS; Liu F; Brusic V; Neuberg D; Kutok JL; Alyea EP; Canning CM; Soiffer RJ; Ritz J; Wu CJ
    Cancer Res; 2010 Feb; 70(4):1344-55. PubMed ID: 20124481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia.
    Schweighofer CD; Coombes KR; Barron LL; Diao L; Newman RJ; Ferrajoli A; O'Brien S; Wierda WG; Luthra R; Medeiros LJ; Keating MJ; Abruzzo LV
    PLoS One; 2011; 6(12):e28277. PubMed ID: 22194822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Membrane characteristics of pathological clones of B-lymphocytes in patients with chronic lymphocytes leukemia (CLL)].
    Pluta A
    Pol Arch Med Wewn; 1989; 82(4-6):195-201. PubMed ID: 2642224
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia.
    Griggio V; Mandili G; Vitale C; Capello M; Macor P; Serra S; Castella B; Peola S; Foglietta M; Drandi D; Omedé P; Sblattero D; Cappello P; Chiarle R; Deaglio S; Boccadoro M; Novelli F; Massaia M; Coscia M
    Oncotarget; 2017 Jan; 8(2):3274-3288. PubMed ID: 27906678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
    Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.
    Amaya-Chanaga CI; Rassenti LZ
    Best Pract Res Clin Haematol; 2016 Mar; 29(1):79-89. PubMed ID: 27742074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
    Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
    Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.